Viera Muzithras

General Counsel at TCR2 THERAPEUTICS INC.

Health Technology

Consumer Services

Profile

Viera Muzithras is currently the Vice President-Regulatory Affairs at TCR2 Therapeutics, Inc. Prior to this, he worked as an Executive Director-Global Regulatory Affairs at Bristol Myers Squibb Co. and as a Senior Director-Regulatory Affairs at Novartis Pharmaceuticals Corp.
from 2008 to 2016.
He obtained his undergraduate degree from Rutgers State University of New Jersey.

Viera Muzithras active positions

Companies	Position	Start
TCR2 THERAPEUTICS INC.	General Counsel	27/05/2020

All active positions of Viera Muzithras

Former positions of Viera Muzithras

Companies	Position	End
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.	Public Communications Contact	01/07/2016
BRISTOL-MYERS SQUIBB COMPANY	General Counsel	-

See the detail of Viera Muzithras's experience

Training of Viera Muzithras

Rutgers State University of New Jersey

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Viera Muzithras's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BRISTOL-MYERS SQUIBB COMPANY	Health Technology

Private companies	2
TCR2 Therapeutics, Inc. TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA.	Health Technology
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.	Health Technology